Stifel Nicolaus Cuts Xylem (NYSE:XYL) Price Target to $166.00

Xylem (NYSE:XYL) had its price objective dropped by stock analysts at Stifel Nicolaus from $172.00 to $166.00 in a note issued to investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the industrial products company’s stock. Stifel Nicolaus’ price objective suggests a potential upside of 32.95% from the company’s current price.

A number of other brokerages have also recently weighed in on XYL. Royal Bank of Canada dropped their price target on Xylem from $163.00 to $162.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. TD Cowen dropped their price target on Xylem from $138.00 to $125.00 and set a “hold” rating on the stock in a research note on Wednesday, November 6th. Citigroup raised Xylem from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $135.00 to $148.00 in a research note on Monday. Robert W. Baird lowered their target price on Xylem from $175.00 to $154.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Finally, UBS Group assumed coverage on Xylem in a research note on Tuesday, August 13th. They set a “buy” rating and a $165.00 target price on the stock. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat.com, Xylem presently has an average rating of “Moderate Buy” and a consensus price target of $149.91.

Xylem Stock Performance

Shares of XYL traded down $3.71 during trading hours on Wednesday, reaching $124.86. 535,507 shares of the company’s stock traded hands, compared to its average volume of 1,231,819. The firm has a market capitalization of $30.33 billion, a price-to-earnings ratio of 36.57, a P/E/G ratio of 2.33 and a beta of 1.05. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.96 and a quick ratio of 1.42. Xylem has a twelve month low of $106.52 and a twelve month high of $146.08. The business’s fifty day simple moving average is $128.44 and its two-hundred day simple moving average is $132.82.

Xylem (NYSE:XYL) last announced its earnings results on Thursday, October 31st. The industrial products company reported $1.11 earnings per share for the quarter, meeting the consensus estimate of $1.11. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The business had revenue of $2.10 billion during the quarter, compared to analysts’ expectations of $2.17 billion. During the same quarter last year, the business posted $0.99 earnings per share. The company’s quarterly revenue was up .2% on a year-over-year basis. Analysts predict that Xylem will post 4.23 earnings per share for the current year.

Institutional Investors Weigh In On Xylem

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Charles Schwab Investment Management Inc. lifted its holdings in Xylem by 0.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,345,768 shares of the industrial products company’s stock worth $181,719,000 after purchasing an additional 5,817 shares during the last quarter. Victory Capital Management Inc. lifted its holdings in shares of Xylem by 9.3% during the third quarter. Victory Capital Management Inc. now owns 1,627,279 shares of the industrial products company’s stock worth $219,731,000 after buying an additional 137,883 shares during the last quarter. BNP Paribas Financial Markets lifted its holdings in shares of Xylem by 16.5% during the third quarter. BNP Paribas Financial Markets now owns 547,435 shares of the industrial products company’s stock worth $73,920,000 after buying an additional 77,639 shares during the last quarter. Groupama Asset Managment lifted its holdings in shares of Xylem by 89.6% during the third quarter. Groupama Asset Managment now owns 16,340 shares of the industrial products company’s stock worth $2,206,000 after buying an additional 7,723 shares during the last quarter. Finally, Cerity Partners LLC lifted its holdings in shares of Xylem by 22.9% during the third quarter. Cerity Partners LLC now owns 115,045 shares of the industrial products company’s stock worth $15,534,000 after buying an additional 21,464 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.